February 24th - $China Pharma (CPHI.US)$ is about to implement a 1-for-5 reverse stock split of shares. The shares will begin trading on a split-adjusted basis from March 6th, 2024.
$China Pharma (CPHI.US)$ slipped 2.65% and closed at $0.088 on February 23rd with a turnover of $153.02K. $China Pharma (CPHI.US)$ now has a total market capitalization of $4.83 million.
What Is a Reverse Stock Split?
A reverse stock split consolidates the number of existing shares of stock held by shareholders into fewer shares. It does not directly impact a company's value. And it can signal a company in distress since it raises the value of otherwise low-priced shares.
Note:
The company's actual implementation is subject to the final disclosure submitted to the exchange. The information provided herein is for reference only.